Výsledky vyhledávání

Akademický článek

An Economic Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease in Norway, Sweden, and Finland

Autor: Pollock RF, Muduma G

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 13, Pp 9-18 (2021)

Richard F Pollock,1 Gorden Muduma2 1Health Economics and Outcomes Research, Covalence Research Ltd, London, UK; 2International Market Access, Pharmacosmos A/S, Holbæk, DenmarkCorrespondence: Richard F PollockHealth Economics and Outcomes Research, C

Externí odkaz: https://doaj.org/article/1856c0fc1908448691093be6e6830a61

Zobrazit plný text záznamu

Akademický článek

A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000

Autor: Pollock RF, Muduma G

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 9, Pp 475-483 (2017)

Richard F Pollock,1 Gorden Muduma2 1Ossian Health Economics and Communications GmbH, Basel, Switzerland; 2Pharmacosmos A/S, Holbaek, Denmark Background and aims: The reported prevalence of iron deficiency anemia (IDA) varies widely but estimates sugg

Externí odkaz: https://doaj.org/article/7a5afdaa4e1a4c0cb8f7a56210617348

Zobrazit plný text záznamu

Akademický článek

Patient survey to identify reasons for non-adherence and elicitation of quality of life concepts associated with immunosuppressant therapy in kidney transplant recipients

Autor: Muduma G, Shupo FC, Dam S, Hawken NA, Aballéa S, Odeyemi I, Toumi M

Publikováno v: Patient Preference and Adherence, Vol 2016, Iss Issue 1, Pp 27-36 (2016)

Gorden Muduma,1 Francis C Shupo,2 Sophie Dam,3 Natalia A Hawken,3 Samuel Aballéa,3 Isaac Odeyemi,1 Mondher Toumi4 1Astellas Pharma Europe Ltd, Chertsey, 2Creativ-Ceutical Ltd, London, UK; 3Creativ-Ceutical Ltd, Paris, 4Public Health (EA 3279), Facul

Externí odkaz: https://doaj.org/article/36e4e6be82d148f6a0637f9220435b69

Zobrazit plný text záznamu

Akademický článek

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales

Autor: Muduma G, Shaw J, Hart WM, Odeyemi A, Odeyemi I

Publikováno v: Patient Preference and Adherence, Vol 2014, Iss default, Pp 1537-1546 (2014)

Gorden Muduma,1 Jane Shaw,2 Warren M Hart,3 Abayomi Odeyemi,3 Isaac Odeyemi21Astellas Pharma Europe Limited, Chertsey, UK; 2Astellas Pharma Limited, Chertsey, UK; 3EcoStat Consulting UK Limited, London, UKBackground: End-stage renal disease is the ir

Externí odkaz: https://doaj.org/article/c0680909085043cf931a7d4d80313c5b

Zobrazit plný text záznamu

Akademický článek

Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence

Autor: Muduma G, Odeyemi I, Smith-Palmer J, Pollock RF

Publikováno v: Patient Preference and Adherence, Vol 2014, Iss default, Pp 391-399 (2014)

Gorden Muduma,1 Isaac Odeyemi,1 Jayne Smith-Palmer,2 Richard F Pollock21Astellas Pharma Europe, Chertsey, UK; 2Ossian Health Economics and Communications, Basel, SwitzerlandBackground and aims: Advagraf is a once-daily prolonged-release formulation o

Externí odkaz: https://doaj.org/article/2deae2c626574e8db3fa98b266a9f168

Zobrazit plný text záznamu